Eili Klein
- Applied Microbiology and Biotechnology top 0.02%
- Antibiotic Use and Resistance 59
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria 27
- Clinical Biochemistry top 0.2%
- Bacterial Identification and Susceptibility Testing 20
- Pollution top 0.5%
- Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus 18
-
- Emergency and Acute Care Studies 20
-
- Respiratory viral infections research 16
- Pneumonia and Respiratory Infections 16
- Sepsis Diagnosis and Treatment 15
- Co-authors
- Ramanan LaxminarayanThomas P. Van BoeckelSumanth GandraDavid L. SmithSimon A. LevinSuraj PantElena MartínezHerman Goossens
- Journals
- Open Forum Infectious Diseases (25 papers)Clinical Infectious Diseases (13 papers)Infection Control and Hospital Epidemiology (13 papers)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Eili Klein
169 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 186
- Applied Microbiology and Biotechnology 2.3k
- Molecular Medicine 1.7k
- Clinical Biochemistry 916
- Pollution 1.3k
- Infectious Diseases 2.0k
Countries citing papers authored by Eili Klein
This map shows the geographic impact of Eili Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eili Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eili Klein more than expected).
Fields of papers citing papers by Eili Klein
This network shows the impact of papers produced by Eili Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eili Klein. The network helps show where Eili Klein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eili Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | Global trends in antibiotic consumption during 2016–2023 and future projections through 2030breakdown → | 2024 | 118 |
| 7 | 2024 | 1 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 8 | |
| 12 | 2022 | 9 | |
| 13 | 2022 | 103 | |
| 14 | 2021 | 90 | |
| 15 | 2021 | 12 | |
| 16 | 2021 | 39 | |
| 17 | 2021 | 5 | |
| 18 | 2019 | 33 | |
| 19 | Global increase and geographic convergence in antibiotic consumption between 2000 and 2015breakdown → | 2018 | 2269 |
| 20 | 2018 | 12 |
About Eili Klein
Eili Klein is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 190 papers that have together received 8.6k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (59 papers), Antibiotic Resistance in Bacteria (27 papers), Emergency and Acute Care Studies (20 papers), Bacterial Identification and Susceptibility Testing (20 papers), Antimicrobial Resistance in Staphylococcus (18 papers), Respiratory viral infections research (16 papers), Pneumonia and Respiratory Infections (16 papers) and Sepsis Diagnosis and Treatment (15 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (2.3k citations), Molecular Medicine (1.7k citations) and Clinical Biochemistry (916 citations). Eili Klein has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Ramanan Laxminarayan, Thomas P. Van Boeckel, Sumanth Gandra, David L. Smith, Simon A. Levin, Suraj Pant, Elena Martínez, Herman Goossens, Ramanan Laxminarayan and Katie K Tseng. Their work appears in journals such as Open Forum Infectious Diseases, Clinical Infectious Diseases, Infection Control and Hospital Epidemiology, Annals of Emergency Medicine and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.